Effect of various antitumor drugs on energetic processes.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology; D001921:Brain / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism; D002330:Carmustine / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D006019:Glycolysis / Q000187:drug effects*; D006918:Hydroxyurea / Q000494:pharmacology; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects*; D010440:Peptichemio / Q000494:pharmacology; D051381:Rats; D013713:Teniposide / Q000494:pharmacology
D000970:Antineoplastic Agents; D003561:Cytarabine; D001761:Bleomycin; D004317:Doxorubicin; D010440:Peptichemio; D013713:Teniposide; D002330:Carmustine; D006918:Hydroxyurea; D003630:Daunorubicin